prolyl-phenylalanyl-arginine-4-nitroanilide and Prostatic Neoplasms

prolyl-phenylalanyl-arginine-4-nitroanilide has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kumar, A; Mikolajczyk, SD; Millar, LS; Saedi, MS	1

Other Studies

1 other study(ies) available for prolyl-phenylalanyl-arginine-4-nitroanilide and Prostatic Neoplasms

Article	Year
Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors. The Prostate, 1998, Jan-01, Volume: 34, Issue:1 Topics: alpha 1-Antichymotrypsin; alpha 1-Antitrypsin; alpha-2-Antiplasmin; Amino Acid Sequence; Animals; Antithrombin III; Arginine; Biomarkers, Tumor; Cell Line; Chromogenic Compounds; Cricetinae; Humans; Kallikreins; Male; Molecular Sequence Data; Oligopeptides; Peptides; Prostatic Neoplasms; Recombinant Fusion Proteins; Serine Proteinase Inhibitors; Serpins; Substrate Specificity; Tissue Kallikreins	1998

Article

Year

Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors.

The Prostate, 1998, Jan-01, Volume: 34, Issue:1

Topics: alpha 1-Antichymotrypsin; alpha 1-Antitrypsin; alpha-2-Antiplasmin; Amino Acid Sequence; Animals; Antithrombin III; Arginine; Biomarkers, Tumor; Cell Line; Chromogenic Compounds; Cricetinae; Humans; Kallikreins; Male; Molecular Sequence Data; Oligopeptides; Peptides; Prostatic Neoplasms; Recombinant Fusion Proteins; Serine Proteinase Inhibitors; Serpins; Substrate Specificity; Tissue Kallikreins

1998